Differentiated thyroid cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who have undergone total thyroidectomy and were pathologically diagnosed with DTC; 2. Meet the postoperative 131I treatment indications for thyroid cancer as outlined in the 2015 ATA "Management Guidelines for Adult Thyroid Nodules and Differentiated Thyroid Cancer". 3. Follow-up time >= 6 months.
Exclusion criteria
Exclusion criteria: 1. History of other malignant tumors or major diseases in the past; 2. Received 131I treatment multiple times; 3. Incomplete follow-up data;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy evaluation (serological indicators of thyroid function, especially important thyroid globulin and antibodies, as well as imaging indicators such as neck color Doppler ultrasound, CT, SPECT, etc.); | — |
Countries
China
Contacts
The First Affiliated Hospital of Nanchang University